Novel Capra hircus-Based Miconazole Nitrate-Loaded Mucoadhesive Nanogels for Enhanced Treatment of Oral Candidiasis doi.org/10.26538/tjnpr/v5i2.28

Main Article Content

Franklin C. Kenechukwu
Samuel A. Abuh
Mark A. Abuh
Mumuni A. Momoh
Adaeze C. Echezona
Anthony A. Attama

Abstract

Natural products play a central role in organic chemistry and are good excipient sources for pharmaceutical formulations. The objective of this study was to formulate and evaluate Capra hircus-based miconazole nitrate (MN)-loaded mucoadhesive nanogels for improved delivery and enhanced antifungal activity in the treatment of oral candidiasis. The method of wet rendering was employed for the extraction of homolipid from Capra hircus. Lipid matrix consisting of 7:3 ratio of the Capra hircus homolipid and Phospholipon® 90G was then prepared by fusion method. MN-loaded nanoparticulate lipospheres were prepared at drug concentrations of 0, 0.25 and 0.5 %w/v by melt homogenization and thereafter characterized with respect to particle size, polydispersity index (PDI), entrapment efficiency (EE%) and drug loading (DL). The nanoparticulate formulations were transformed into nanogels by dispersion in Polycarbophil® and thereafter characterized in terms of drug content, rheology, mucoadhesion and compatibility by Fourier transform infra-red (FT-IR) spectroscopy. In vitro drug dissolution in simulated salivary fluid (SSF, pH 6.8) and antifungal activity were evaluated and compared with a marketed MN-loaded oral gel formulation. The nanoparticles with acceptable PDI values (0.08-0.7), EE% (48.69-65.21), DL (18.20-23.94) and average particle size (135.9-339.0 nm) were obtained. Capra hircus-based mucoadhesive nanogels exhibited good physicochemical properties with no strong chemical interaction between MN and the excipients used in the formulation, and gave significantly (p<0.05) greater drug release and anticandidal activity than marketed gel. Carpra hircus-based mucoadhesive nanogels can be used as an alternative sustained delivery system for MN in localized treatment of oral candidiasis.

Article Details

How to Cite
Kenechukwu, F. C., Abuh, S. A., Abuh, M. A., Momoh, M. A., Echezona, A. C., & Attama, A. A. (2021). Novel Capra hircus-Based Miconazole Nitrate-Loaded Mucoadhesive Nanogels for Enhanced Treatment of Oral Candidiasis: doi.org/10.26538/tjnpr/v5i2.28. Tropical Journal of Natural Product Research (TJNPR), 5(2), 382–388. Retrieved from https://tjnpr.org/index.php/home/article/view/793
Section
Articles

References

Zempsky WT. Alternative routes of drug administration-advantages and disadvantages (subject review). Pediat 1998; 101:730–731.

Jorge FC, Paula CF, Patricia A, Rosemeyre C, Fonseca AC, Góis JR, Gil MH. Drug delivery systems: Advanced technologies potentially applicable in personalized treatments. EPMA J .2010; 7:10-15.

Vilayat AS and Muhammad A. Considerations in developing sublingual tablets. An overview. Pharm Techn Comm. 2014.

Punitha S and Girish Y. Polymers in mucoadhesive buccal drug delivery system: A review. Int J Res Pharm Sci 2010; 1:170–186.

Vazquez JA and Sobel JD. Candidiasis. Clinical Mycology, Dismukes WE, Pappas PG, and Sobel JD, eds. Oxford University press. 2003. 143-187 p.

Gubbins P and Anaissie E. Overview of antifungal agents. Pharmacy Practice News special edition. 2006; 6-9 p.

Ghannoum MA and Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. ClinMicrobiol Rev. 1999; 12:501.

Collin D. Ketoconazole, in “Therapeutic Drugs”, 2 nd ed. Churchill Livingstone, New York 1999. 13 p.

Budavari S. The Merck Index, 12th edn., Merck and Co, NJ. ; 1996. 894 p.

Majekodunmi SO and Matthew EB. Evaluation of Goat Fat as Potential Co-Lubricant in Pharmaceutical Tablet Dosage Form. J. Pharm.; 2014; 4:01-09.

Momoh MA, Akpa PA, Attama AA. Phospholipon 90G based SLMs loaded with ibuprofen: An oral antiinflammatory and astrointestinal sparing evaluation in rats. Pak J Zool. 2012; 44(6):1657-1664.

Boriollo MF, Bassi RC, dos Santos Nascimento CM, Feliciano LM, Francisco SB, Barros LM. Distribution and hydrolytic enzyme characteristics of Candida albicans strains isolated from diabetic patients and their non-diabetic consorts. Oral Microbiol Immunol.

; 24(6):437-450

William DJ, Richard PV, Paul K, Franklin F. Mucosal Candidiasis Clinical Presentation Retrieve from http://emedicine.medscape.com 2016. Accesed 26 Aug, 2020

Momoh MA, Kenechukwu FC, Nnamani PO, Umetiti JC. Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres. Drug Deliv. 2015;22(6):837-848.

Chan Li, Xianlei Li, Shuyi Li, YuhuaWeng, Kaiyuan Wang, Tingbin Zhang, Shizhu Chen, Xuexia Lu, Yonggang Jiang, Jing Xu, Xingjie Liang. Development and Validation of a Method for Determination of Encapsulation Efficiency of CPT-11/DSPE- mPEG2000 Nanoparticles. Med Chem. 2016; 6:345-348.

Venkatesh B, Indira S, Prathima S. Formulation and evaluation of miconazole nitrate as a cubosomal topical gel. J. Global Trends in Pharm. Sci .2014 ; 5(4):2037-2047.

Jaleh V, Valiollah H, Sindokht S. Lipid nanocapsulebased gels for enhancement of transdermal delivery of ketorolac tromethamine. J Drug Deliv. 2011; 2011:571272.

Kenechukwu FC, Attama AA, Ibezim EC. Novel solidified reverse micellar solution-based mucoadhesive nano lipid gels encapsulating

miconazole nitrate - loaded nanoparticles for improved treatment of oropharyngeal candidiasis. JMicroen. 2017; 34(6):592-609.

Trnovsky J, Merz W, Della-Latta P,Wu F, ArendrupMC, Stender H. Rapid and Accurate Identification of Candida albicansIsolates by Use of PNA FISHFlow,2008;46(4): 1537–1540. doi:10.1128/jcm.00030-08

Prajapati RK, Mahajan HS, Surana SJ. PLGA based mucoadhesive microsphere for nasal drug delivery: invitro/ ex vivo studies. Ind J Novel Drug Deliv. 2011; 3(1):9-16.

Yakubu BN, Mark OA, Ruth EO, Adebukola AS, ADebola O, Samuel O. Antimicrobial susceptibility of Escherichia coli and other Coliforms isolated from urine of asymptomatic patient. Afr J Microbiol Res.2010; 5(3):184-191.

Buzea C , Ivan IP, Kevin R. Nanomaterials and nanoparticles: Sources and toxicity. Biointerph. 2007; 2(4)17-172.

U.S Pharmacopeia. 2006. Retrieved from http://www.pharmacopeia.cn.255rm. Accessed 15 Sep.2019

The Physics of Whipped Cream | Science Mission Directorate.2008.

Gu JM, Robinson JR, Leung SH. Binding of acrylic polymers to Mucin/epithelia Surfaces: structures-property relationships. Crit Rev

Ther Drug Carr Syst. 1998; 5:21-67

http://www.glossary.oilfield.slb.com. Quick look for heavy oils Accessed 1 Oct. 2016.Quick look for heavy oils

Xu S, Cavera VL, Rogers MA, Huang O, Zubovsiv K, Chikindas ML. benzoyl Peroxide formulated polycarbophil/ carbopol 934P hydrogel with selective antimicrobial activity, potentially beneficial for treatment and prevention of bacterial vaginosis. Infect Dis Obstet Gynecol. 2013; 2013:90935.

Bhalekar MR, Pokharkar V, Madgulkar A, Patil N. Preparation and evaluation of miconazole nitrateloaded solid lipid nanoparticles for topical delivery. AAPS Pharm Sci Tech. 2009; 10:289–296.

Most read articles by the same author(s)